Abstract
Based on maximum likelihood estimates obtained from mixed-effects linear models, closed-form power functions are derived to detect two-way and three-way interactions that involve longitudinal course of outcome over time in clinical trials. Sample size estimates are shown to decrease with increasing within-subject correlations. It is further shown that when clinical trial designs are balanced in group sizes, the sample size required to detect an effect size for a three-way interaction is exactly fourfold that required to detect the same effect size of a two-way interaction. Furthermore, this fourfold relationship virtually holds for unbalanced allocations of subjects if one factor is balanced in the three-way interaction model. Simulations are presented that verify the sample size estimates for two-way and three-way interactions.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 787-802 |
| Number of pages | 16 |
| Journal | Journal of Biopharmaceutical Statistics |
| Volume | 20 |
| Issue number | 4 |
| DOIs | |
| State | Published - Jul 2010 |
Keywords
- Clinical trials
- Effect size
- Power function
- Sample size requirements
- Three-way interaction
- Two-way interaction
ASJC Scopus subject areas
- Statistics and Probability
- Pharmacology
- Pharmacology (medical)
Fingerprint
Dive into the research topics of 'Sample sizes required to detect two-way and three-way interactions involving slope differences in mixed-effects linear models'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS